The global Smart Pills Market ,valued at US$0.61 billion in 2023, is forecasted to grow at a robust CAGR of 11.2%, reaching US$0.69 billion in 2024 and an impressive US$1.30 billion by 2030. The key ...
All of the board of directors nominees listed in the Circular were re-elected as directors of Microbix ... and reagents or media to support molecular diagnostic testing (e.g., its DxTM for ...
In connection with AcouSort's announcement of its plan to carry out a rights issue, several shareholders have contacted the company with questions regarding both the issue itself and how the managemen ...
We’re excited to announce the judges of the 2025 Innovation by Design Awards. Innovation by Design honors the best projects ...
The Secretariat ensures tax dollars are spent wisely and effectively for Canadians. We oversee and provide guidance to the Treasury Board of Ministers on how government is managed and how it regulates ...
The global Drug Discovery Services Market , valued at US$14.89 billion in 2024, is forecasted to grow at a robust CAGR of 10.7%, reaching US$16.36 billion in 2025 and an impressive US$27.23 billion by ...
IMDb.com, Inc. takes no responsibility for the content or accuracy of the above news articles, Tweets, or blog posts. This content is published for the entertainment of our users only. The news ...
(Nasdaq: SNTI) (“Senti Bio” or the “Company”), a clinical-stage biotechnology company developing ... Appointed Fran Schulz and Feng Hsiung to the Board of Directors ("Board"): In December 2024, Fran ...
Consequently, both will cease to be Independent Non-executive Directors of the Company at the conclusion of the AGM. Upon their retirement, they will also step down from their roles as chairmen and ...
ISC Board Class 12 Biology Sample Paper 2024-25: The Council for the Indian School Certificate Examinations (CISCE) has made available the Biology sample paper for the exam tomorrow. Keep reading ...
The Plan was adopted by the Company’s Board of Directors on August 5, 2022. Senti Bio is a clinical-stage biotechnology company developing a new generation of cell and gene therapies for patients ...
The company has also indicated it will advise at a later stage whether all of the nominees are, in the view of NZME’s directors, eligible under NZX rules to be independent board members of the ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果